Shandong Keyuan Pharmaceutical Co (SZSE:301281) Beta: 0.3869 (As of Jul. 12, 2026)


SZSE:301281 Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
67 GF Score
Price ¥50.42
GF Value ¥30.41
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Shandong Keyuan Pharmaceutical Co Beta?

Shandong Keyuan Pharmaceutical Co SZSE:301281 -1.12% 67 Beta is 0.3869 as of Jul. 12, 2026. GuruFocus rates SZSE:301281 with a GF Score™ of 67/100 and a GF Value™ of ¥30.41 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-12), Shandong Keyuan Pharmaceutical Co's Beta is 0.3869.


Shandong Keyuan Pharmaceutical Co  (SZSE:301281) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Shandong Keyuan Pharmaceutical Co Beta Related Terms


Shandong Keyuan Pharmaceutical Co Beta Historical Data

* Premium members only.

The historical data trend for Shandong Keyuan Pharmaceutical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Keyuan Pharmaceutical Co Beta Chart

Shandong Keyuan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Shandong Keyuan Pharmaceutical Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.42

SZSE:301281 vs LLY, JNJ, ABBV: Beta Comparison

For the Drug Manufacturers - General subindustry, Shandong Keyuan Pharmaceutical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Keyuan Pharmaceutical Co Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Keyuan Pharmaceutical Co's Beta distribution charts can be found below:

* The bar in red indicates where Shandong Keyuan Pharmaceutical Co's Beta falls into.


SZSE:301281
67GF Score
Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Keyuan Pharmaceutical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3869 mean?
Shandong Keyuan Pharmaceutical Co (SZSE:301281) has a Beta of 0.3869 as of Jul. 12, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shandong Keyuan Pharmaceutical Co and its competitors.
Is Shandong Keyuan Pharmaceutical Co's Beta too high?
Shandong Keyuan Pharmaceutical Co's current Beta is 0.3869. Overall, Shandong Keyuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Keyuan Pharmaceutical Co's Beta compare to LLY and JNJ?
Shandong Keyuan Pharmaceutical Co's Beta of 0.3869 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shandong Keyuan Pharmaceutical Co and its competitors. Shandong Keyuan Pharmaceutical Co's current Beta is 0.3869. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Keyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co (SZSE:301281) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥30.41, compared to a current price of ¥50.42 — trading 65.8% above its estimated fair value. The current Beta is 0.3869. Shandong Keyuan Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Shandong Keyuan Pharmaceutical Co (SZSE:301281), the current Beta is 0.3869 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥50.42 is trading 65.8% above its estimated GF Value™ of ¥30.41. GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SZSE:301281:

  • Beta: 0.3869
  • GF Value™: ¥30.41 vs. price of ¥50.42 (65.8% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Keyuan Pharmaceutical Co Business Description

Address Keyuan Street, Shandong Shanghe Economic Development Zone, Shandong Province, Jinan, CHN, 251601
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score

Get the complete analysis for SZSE:301281

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥50.42
Price
¥30.41
GF Value